The standardized uptake value calculated from 111In-ibritumomab tiuxetan single-photon emission computed tomography/computed tomography is a useful predictor of the clinical response in patients treated by 90Y- ibritumomab tiuxetan therapy
| Autor: | Kume, Ayaka, Toriihara, Akira, Shimizu, Ryo, Harata, Naoki, Isogai, Jun, Tanaka, Hiroaki |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Aged
80 and over Male Lymphoma B-Cell Single Photon Emission Computed Tomography Computed Tomography Biopsy Indium Radioisotopes Antibodies Monoclonal Disease Management Middle Aged Prognosis Indolent B-cell lymphoma Progression-Free Survival Treatment Outcome ibritumomab tiuxetan standardized uptake value Antineoplastic Combined Chemotherapy Protocols Biomarkers Tumor Image Processing Computer-Assisted Humans Original Article Female single-photon emission computed tomography/computed tomography Aged Neoplasm Staging Retrospective Studies |
| Zdroj: | Journal of Clinical and Experimental Hematopathology : JCEH |
| ISSN: | 1880-9952 1346-4280 |
| Popis: | 90Y-Ibritumomab tiuxetan (IT) therapy is a radioimmunotherapy for indolent B-cell lymphoma. Several predictors of insufficient therapeutic effects have been reported. We performed a retrospective study at a single institute to investigate whether 111In SPECT/CT can predict the therapeutic effects and grade of cytopenia due to 90Y-IT therapy. We enrolled 16 consecutive patients who underwent 90Y-IT therapy, including 15 who underwent 111In-IT SPECT/CT. After 90Y-IT therapy, there were 4 patients in complete remission in whom the lesion SUVmax on 111In-IT SPECT/CT and soluble IL-2 receptor were significantly lower than those of the other patients (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|